Clinical trial
Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer
NCT02476539
Study timeline
Study start (actual)2015-10-14Date precision: day
Registry last updated2024-03-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HER2 Positive Breast Cancerunresolved
Interventions
Hemay022DRUG
Sponsors & collaborators
Tianjin Hemay Pharmaceutical Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02476539 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.